•
Dec 31, 2021

Summit Therapeutics Q4 2021 Earnings Report

Total Revenue
$251K
Previous year: $185K
+35.7%
EPS
-$0.28
Previous year: -$0.18
+55.6%
Gross Profit
$251K
Previous year: $185K
+35.7%
Cash and Equivalents
$71.8M
Previous year: $66.4M
+8.1%
Free Cash Flow
-$9.3M
Previous year: -$8.02M
+15.9%
Total Assets
$113M
Previous year: $102M
+10.6%

Summit Therapeutics

Summit Therapeutics